ABBOTT LABORATORIES (ABT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:ABT - US0028241000 - Common Stock
123.25 USD
-1.05 (-0.84%)
Taking everything into account, ABT scores 6 out of 10 in our fundamental rating. ABT was compared to 185 industry peers in the Health Care Equipment & Supplies industry. ABT has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. ABT is not valued too expensively and it also shows a decent growth rate. Finally ABT also has an excellent dividend rating. These ratings could make ABT a good candidate for dividend and quality investing.
1. Profitability
1.1 Basic Checks
- In the past year ABT was profitable.
- ABT had a positive operating cash flow in the past year.
- In the past 5 years ABT has always been profitable.
- ABT had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- ABT has a Return On Assets of 16.60%. This is amongst the best in the industry. ABT outperforms 97.30% of its industry peers.
- With an excellent Return On Equity value of 27.43%, ABT belongs to the best of the industry, outperforming 98.38% of the companies in the same industry.
- With an excellent Return On Invested Capital value of 9.90%, ABT belongs to the best of the industry, outperforming 89.19% of the companies in the same industry.
- The Average Return On Invested Capital over the past 3 years for ABT is in line with the industry average of 8.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROIC | 9.9% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
1.3 Margins
- ABT's Profit Margin of 31.88% is amongst the best of the industry. ABT outperforms 97.84% of its industry peers.
- In the last couple of years the Profit Margin of ABT has grown nicely.
- With an excellent Operating Margin value of 18.29%, ABT belongs to the best of the industry, outperforming 89.73% of the companies in the same industry.
- In the last couple of years the Operating Margin of ABT has grown nicely.
- The Gross Margin of ABT (56.19%) is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of ABT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% |
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
2. Health
2.1 Basic Checks
- ABT has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- The number of shares outstanding for ABT remains at a similar level compared to 1 year ago.
- The number of shares outstanding for ABT has been reduced compared to 5 years ago.
- The debt/assets ratio for ABT has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 5.70 indicates that ABT is not in any danger for bankruptcy at the moment.
- With a decent Altman-Z score value of 5.70, ABT is doing good in the industry, outperforming 79.46% of the companies in the same industry.
- ABT has a debt to FCF ratio of 1.87. This is a very positive value and a sign of high solvency as it would only need 1.87 years to pay back of all of its debts.
- ABT's Debt to FCF ratio of 1.87 is amongst the best of the industry. ABT outperforms 88.11% of its industry peers.
- A Debt/Equity ratio of 0.23 indicates that ABT is not too dependend on debt financing.
- With a Debt to Equity ratio value of 0.23, ABT perfoms like the industry average, outperforming 56.22% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Altman-Z | 5.7 |
ROIC/WACC1
WACC9.87%
2.3 Liquidity
- ABT has a Current Ratio of 1.70. This is a normal value and indicates that ABT is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.70, ABT is doing worse than 68.65% of the companies in the same industry.
- A Quick Ratio of 1.24 indicates that ABT should not have too much problems paying its short term obligations.
- ABT has a worse Quick ratio (1.24) than 65.95% of its industry peers.
- ABT does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 10.40% over the past year.
- ABT shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.59% yearly.
- Looking at the last year, ABT shows a small growth in Revenue. The Revenue has grown by 6.37% in the last year.
- Measured over the past years, ABT shows a small growth in Revenue. The Revenue has been growing by 5.63% on average per year.
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
3.2 Future
- The Earnings Per Share is expected to grow by 9.68% on average over the next years. This is quite good.
- ABT is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.22% yearly.
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 24.70, which indicates a rather expensive current valuation of ABT.
- Based on the Price/Earnings ratio, ABT is valued a bit cheaper than the industry average as 79.46% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of ABT to the average of the S&P500 Index (27.30), we can say ABT is valued inline with the index average.
- The Price/Forward Earnings ratio is 21.50, which indicates a rather expensive current valuation of ABT.
- Based on the Price/Forward Earnings ratio, ABT is valued a bit cheaper than 79.46% of the companies in the same industry.
- ABT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.04.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.7 | ||
| Fwd PE | 21.5 |
4.2 Price Multiples
- 76.22% of the companies in the same industry are more expensive than ABT, based on the Enterprise Value to EBITDA ratio.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of ABT indicates a somewhat cheap valuation: ABT is cheaper than 78.92% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.98 | ||
| EV/EBITDA | 19.83 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- ABT has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.16
PEG (5Y)3.26
EPS Next 2Y10.8%
EPS Next 3Y10.58%
5. Dividend
5.1 Amount
- With a Yearly Dividend Yield of 2.00%, ABT has a reasonable but not impressive dividend return.
- Compared to an average industry Dividend Yield of 0.19, ABT pays a better dividend. On top of this ABT pays more dividend than 96.22% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.92, ABT has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
5.2 History
- The dividend of ABT is nicely growing with an annual growth rate of 11.40%!
- ABT has been paying a dividend for at least 10 years, so it has a reliable track record.
- ABT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.4%
Div Incr Years34
Div Non Decr Years34
5.3 Sustainability
- 28.93% of the earnings are spent on dividend by ABT. This is a low number and sustainable payout ratio.
- ABT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP28.93%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
NYSE:ABT (1/14/2026, 10:22:09 AM)
123.25
-1.05 (-0.84%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-15 2025-10-15/bmo
Earnings (Next)01-20 2026-01-20/amc
Inst Owners81.33%
Inst Owner Change0.11%
Ins Owners0.45%
Ins Owner Change-0.06%
Market Cap214.32B
Revenue(TTM)43.84B
Net Income(TTM)13.98B
Analysts79.43
Price Target146.81 (19.12%)
Short Float %0.92%
Short Ratio2.58
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2% |
Yearly Dividend2.21
Dividend Growth(5Y)11.4%
DP28.93%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-15 2026-01-15 (0.63)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.82%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.58%
EPS beat(4)1
Avg EPS beat(4)-0.52%
Min EPS beat(4)-1.16%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.07%
EPS beat(12)7
Avg EPS beat(12)1.63%
EPS beat(16)11
Avg EPS beat(16)5.69%
Revenue beat(2)0
Avg Revenue beat(2)-0.81%
Min Revenue beat(2)-1.29%
Max Revenue beat(2)-0.33%
Revenue beat(4)0
Avg Revenue beat(4)-1.08%
Min Revenue beat(4)-1.37%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-0.75%
Revenue beat(12)4
Avg Revenue beat(12)0.15%
Revenue beat(16)8
Avg Revenue beat(16)1.85%
PT rev (1m)0%
PT rev (3m)1.54%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.48%
EPS NY rev (1m)0%
EPS NY rev (3m)0.15%
Revenue NQ rev (1m)0.04%
Revenue NQ rev (3m)0.13%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.7 | ||
| Fwd PE | 21.5 | ||
| P/S | 4.89 | ||
| P/FCF | 30.98 | ||
| P/OCF | 23.5 | ||
| P/B | 4.21 | ||
| P/tB | 10.02 | ||
| EV/EBITDA | 19.83 |
EPS(TTM)4.99
EY4.05%
EPS(NY)5.73
Fwd EY4.65%
FCF(TTM)3.98
FCFY3.23%
OCF(TTM)5.24
OCFY4.25%
SpS25.21
BVpS29.3
TBVpS12.3
PEG (NY)2.16
PEG (5Y)3.26
Graham Number57.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| ROCE | 11.52% | ||
| ROIC | 9.9% | ||
| ROICexc | 11.13% | ||
| ROICexgc | 21.33% | ||
| OM | 18.29% | ||
| PM (TTM) | 31.88% | ||
| GM | 56.19% | ||
| FCFM | 15.78% |
ROA(3y)11.2%
ROA(5y)9.84%
ROE(3y)20.61%
ROE(5y)19.06%
ROIC(3y)10.45%
ROIC(5y)10.18%
ROICexc(3y)12.18%
ROICexc(5y)11.89%
ROICexgc(3y)32.65%
ROICexgc(5y)35.03%
ROCE(3y)12.16%
ROCE(5y)11.86%
ROICexgc growth 3Y-24.08%
ROICexgc growth 5Y-8.19%
ROICexc growth 3Y-10.71%
ROICexc growth 5Y6.04%
OM growth 3Y-5.79%
OM growth 5Y2.63%
PM growth 3Y24.85%
PM growth 5Y22.55%
GM growth 3Y-0.89%
GM growth 5Y-1.07%
F-Score7
Asset Turnover0.52
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.23 | ||
| Debt/FCF | 1.87 | ||
| Debt/EBITDA | 1.04 | ||
| Cap/Depr | 70.33% | ||
| Cap/Sales | 5.02% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 81.77% | ||
| Profit Quality | 49.49% | ||
| Current Ratio | 1.7 | ||
| Quick Ratio | 1.24 | ||
| Altman-Z | 5.7 |
F-Score7
WACC9.87%
ROIC/WACC1
Cap/Depr(3y)63.63%
Cap/Depr(5y)61.92%
Cap/Sales(3y)4.94%
Cap/Sales(5y)5.1%
Profit Quality(3y)82.78%
Profit Quality(5y)99.6%
High Growth Momentum
Growth
EPS 1Y (TTM)10.4%
EPS 3Y-3.58%
EPS 5Y7.59%
EPS Q2Q%7.44%
EPS Next Y11.44%
EPS Next 2Y10.8%
EPS Next 3Y10.58%
EPS Next 5Y9.68%
Revenue 1Y (TTM)6.37%
Revenue growth 3Y-0.88%
Revenue growth 5Y5.63%
Sales Q2Q%6.9%
Revenue Next Year6.44%
Revenue Next 2Y7.2%
Revenue Next 3Y7.33%
Revenue Next 5Y7.22%
EBIT growth 1Y15.18%
EBIT growth 3Y-6.62%
EBIT growth 5Y8.41%
EBIT Next Year27.08%
EBIT Next 3Y15.42%
EBIT Next 5Y13.66%
FCF growth 1Y53.98%
FCF growth 3Y-9.78%
FCF growth 5Y7.14%
OCF growth 1Y39.24%
OCF growth 3Y-6.69%
OCF growth 5Y6.88%
ABBOTT LABORATORIES / ABT FAQ
What is the fundamental rating for ABT stock?
ChartMill assigns a fundamental rating of 6 / 10 to ABT.
What is the valuation status of ABBOTT LABORATORIES (ABT) stock?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABT). This can be considered as Fairly Valued.
What is the profitability of ABT stock?
ABBOTT LABORATORIES (ABT) has a profitability rating of 8 / 10.
What are the PE and PB ratios of ABBOTT LABORATORIES (ABT) stock?
The Price/Earnings (PE) ratio for ABBOTT LABORATORIES (ABT) is 24.7 and the Price/Book (PB) ratio is 4.21.
Can you provide the expected EPS growth for ABT stock?
The Earnings per Share (EPS) of ABBOTT LABORATORIES (ABT) is expected to grow by 11.44% in the next year.